Article

Transcriptomics based prediction of metastasis in TNBC patients: Challenges in cross-platforms validation

2021-09-20

Abstract excerpt

Triple-negative breast cancer (TNBC) is more prone to metastasis and recurrence than other breast cancer subtypes. This study aimed to identify genes that can act as diagnostic biomarkers for predicting lymph node metastasis in TNBC patients. The transcriptomic data of TNBC with or without lymph node metastasis was acquired from TCGA, and the differentially expressed genes were identified. Further, logistic-regres...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 197a31e1-379f-5951-b0dd-7f1a64ba97d7
DOI: 10.1101/2021.09.17.460812

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transcriptomics based prediction of metastasis in TNBC patients: Challenges in cross-platforms validationDOI 10.1101/2021.09.17.460812Read

Integrated transcriptomic meta-analysis provides novel insights into breast cancer molecular subtypesSemantic proximity Read

Secondary Transcriptomic Analysis of Triple Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific BiomarkersSemantic proximity Read

Development of a Prognostic Model Based on Identification of EMT-related LncRNAs in Triple Negative Breast CancerSemantic proximity Read

Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patientsSemantic proximity Read

Deciphering the recurrence-associated coding and non-coding genes in triple-negative breast cancer using an integrated omics approachSemantic proximity Read

Exploration of prognostic value and underlying mechanism of P2RY14 in triple negative breast cancer by multi-omicsSemantic proximity Read

In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkersSemantic proximity Read

Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast CancerSemantic proximity Read

An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancerSemantic proximity Read

Machine learning analysis identifies genes differentiating triple negative breast cancersSemantic proximity Read

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancerSemantic proximity Read

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancerSemantic proximity Read